Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 18/6/20041 min de lectura
Notice of Approval of Abbreviated New Animal Drug Application; Dexamethasone Sodium Phosphate Injection
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration's Center for Veterinary Medicine (CVM) is providing notice that it has approved an original abbreviated new animal drug application (ANADA) filed by Cross Vetpharm Group Ltd. The ANADA provides for the veterinary prescription use of dexamethasone sodium phosphate injectable solution as a rapid adrenal glucocorticoid and/or anti-inflammatory agent in horses. The applicable sections of the regulations did not require amendment.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →